Vikas V. Dukhande - Search Results

Year	Number of Results
2006	1
2007	1
2008	1
2009	1
2010	1
2011	3
2013	1
2014	2
2015	1
2019	4
2020	5
2021	2
2022	2

1

Methods for Studying TNFα-Induced Autophagy.

Najafi S, Abo-Ali EM, Dukhande VV. Najafi S, et al. Among authors: dukhande vv. Methods Mol Biol. 2020;2108:131-146. doi: 10.1007/978-1-0716-0247-8_12. Methods Mol Biol. 2020. PMID: 31939177

2

Optimizing the aryl-triazole of cjoc42 for enhanced gankyrin binding and anti-cancer activity.

Kanabar D, Farrales P, Kabir A, Juang D, Gnanmony M, Almasri J, Torrents N, Shukla S, Gupta V, Dukhande VV, D'Souza A, Muth A. Kanabar D, et al. Among authors: dukhande vv. Bioorg Med Chem Lett. 2020 Sep 1;30(17):127372. doi: 10.1016/j.bmcl.2020.127372. Epub 2020 Jul 2. Bioorg Med Chem Lett. 2020. PMID: 32738965

3

Recent advances in the application of nanomedicine for the treatment of diabetes.

Vemana HP, Dukhande VV. Vemana HP, et al. Among authors: dukhande vv. Nanomedicine (Lond). 2022 Jan;17(2):65-69. doi: 10.2217/nnm-2021-0338. Epub 2022 Jan 5. Nanomedicine (Lond). 2022. PMID: 34983192 No abstract available.

4

Nanoformulation of PROteolysis TArgeting Chimera targeting 'undruggable' c-Myc for the treatment of pancreatic cancer.

Saraswat A, Patki M, Fu Y, Barot S, Dukhande VV, Patel K. Saraswat A, et al. Among authors: dukhande vv. Nanomedicine (Lond). 2020 Aug;15(18):1761-1777. doi: 10.2217/nnm-2020-0156. Epub 2020 Jul 23. Nanomedicine (Lond). 2020. PMID: 32698663

5

Nuclear Glycogenolysis Modulates Histone Acetylation in Human Non-Small Cell Lung Cancers.

Sun RC, Dukhande VV, Zhou Z, Young LEA, Emanuelle S, Brainson CF, Gentry MS. Sun RC, et al. Among authors: dukhande vv. Cell Metab. 2019 Nov 5;30(5):903-916.e7. doi: 10.1016/j.cmet.2019.08.014. Epub 2019 Sep 12. Cell Metab. 2019. PMID: 31523006 Free PMC article.

6

Synthesis and Biological Evaluation of Structurally Diverse Benzimidazole Scaffolds as Potential Chemotherapeutic Agents.

Barasa L, Vemana HP, Surubhotla N, Ha SS, Kong J, Yong A, Croft JL, Dukhande VV, Yoganathan S. Barasa L, et al. Among authors: dukhande vv. Anticancer Agents Med Chem. 2020;20(3):301-314. doi: 10.2174/1871520619666191028101506. Anticancer Agents Med Chem. 2020. PMID: 31746304

7

Structural modification of the aryl sulfonate ester of cjoc42 for enhanced gankyrin binding and anti-cancer activity.

Kanabar D, Farrales P, Gnanamony M, Almasri J, Abo-Ali EM, Otmankel Y, Shah H, Nguyen D, El Menyewi M, Dukhande VV, D'Souza A, Muth A. Kanabar D, et al. Among authors: dukhande vv. Bioorg Med Chem Lett. 2020 Feb 15;30(4):126889. doi: 10.1016/j.bmcl.2019.126889. Epub 2019 Dec 16. Bioorg Med Chem Lett. 2020. PMID: 31902711

8

A novel gene therapy for neurodegenerative Lafora disease via EPM2A-loaded DLinDMA lipoplexes.

Vemana HP, Saraswat A, Bhutkar S, Patel K, Dukhande VV. Vemana HP, et al. Among authors: dukhande vv. Nanomedicine (Lond). 2021 Jun;16(13):1081-1095. doi: 10.2217/nnm-2020-0477. Epub 2021 May 7. Nanomedicine (Lond). 2021. PMID: 33960213

9

Galactose-decorated liver tumor-specific nanoliposomes incorporating selective BRD4-targeted PROTAC for hepatocellular carcinoma therapy.

Saraswat A, Vemana HP, Dukhande VV, Patel K. Saraswat A, et al. Among authors: dukhande vv. Heliyon. 2022 Jan 3;8(1):e08702. doi: 10.1016/j.heliyon.2021.e08702. eCollection 2022 Jan. Heliyon. 2022. PMID: 35036599 Free PMC article.

10

Inhibition of glycogen catabolism induces intrinsic apoptosis and augments multikinase inhibitors in hepatocellular carcinoma cells.

Barot S, Abo-Ali EM, Zhou DL, Palaguachi C, Dukhande VV. Barot S, et al. Among authors: dukhande vv. Exp Cell Res. 2019 Aug 15;381(2):288-300. doi: 10.1016/j.yexcr.2019.05.017. Epub 2019 May 22. Exp Cell Res. 2019. PMID: 31128107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results